Also Known As: Glimepiride, Amaryl
Glimepiride is a medium-to-long acting sulfonylurea anti-diabetic drug. It is marketed as Amaryl by Sanofi-Aventis and GLIMY by Dr.Reddy's Labs.
It is sometimes classified as the first third-generation sulfonylurea, and sometimes classified as second-generation.
Glimepiride is indicated to treat type 2 diabetes mellitus; its mode of action is to increase insulin production by the pancreas. It is not used for type 1 diabetes because the pancreas is no longer able to produce insulin.
Its use is contraindicated in patients with hypersensitivity to glimepiride or other sulfonylureas, and during pregnancy.